Health Care: Drugs

Enanta Pharmaceuticals Inc (ENTA: NASDAQ)

$26.7 n/a | n/a%
02/12/16 - 04:00 PM ET
Company Income Statement
Sep 2015 Sep 2014 Sep 2013 Sep 2012
Sales 160.88M 47.74M 32.05M 41.71M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 160.88M 47.74M 32.05M 41.71M
Selling, General, and Administrative Expenses 13.54M 10.02M 6.18M 5.30M
Research & Development 23.19M 18.74M 16.84M 15.12M
Operating Income before D & A (EBITDA) 124.15M 18.98M 9.03M 21.29M
Depreciation & Amortization 2.88M 2.47M 1.48M 762.00K
Interest Income 968.00K 467.00K 248.00K 118.00K
Other Income - Net 347.00K -166.00K 381.00K -8.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 122.58M 16.81M 8.18M 20.64M
Interest Expense 8.00K 18.00K 31.00K 0.00
Pre-Tax Income 122.57M 16.80M 8.14M 20.64M
Income Taxes 46.46M -15.17M 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 78.99M 34.44M 9.63M 21.40M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 78.99M 34.44M 9.63M 21.40M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 78.99M 34.44M 9.63M 21.40M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
78.99M 34.44M 9.63M 21.40M
Preferred Dividends
Net Income Available To Common 78.99M 34.44M 7.10M 21.40M
Basic EPS from Continuing Ops. 4.23 1.88 -0.67 1.68
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 4.23 1.88 -0.67 1.68
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 4.23 1.88 -0.67 1.68
Basic Normalized Net Income/Share 4.23 1.88 n.a. 1.68
EPS fr Continuing Ops. 4.09 1.80 -0.67 1.51
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 4.09 1.80 -0.67 1.51
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 4.09 1.80 -0.67 1.51
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
4.09 1.80 n.a. 1.51
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ENTA

Latest ENTA Headlines from TheStreet

More Financial News for ENTA

Press Releases for ENTA

See All Press Releases

Partner Headlines for ENTA

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter